WG Biotech ApS - May 28, 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
10%+ Owner
Signature
/s/ Johan Wedell-Wedellsborg
Stock symbol
YMAB
Transactions as of
May 28, 2021
Transactions value $
-$1,152,648
Form type
4
Date filed
6/2/2021, 04:31 PM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$908K -25K -0.56% $36.34* 4.45M May 28, 2021 Direct F1
transaction YMAB Common Stock Sale -$244K -6.86K -0.15% $35.57* 4.45M Jun 1, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $35.69 to $37.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $35.50 to $35.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.